Get the Stockscreener App
34.46
3.14%
1.05
Lyell Immunopharma Inc Stock (LYEL) Forecast
The Lyell Immunopharma Inc (LYEL) stock price forecast for the next 30 days is generally negative, with an average analyst price target of $3.5687, representing a -89.64% decrease from the current price of $34.46. The highest analyst price target is $3.5095, and the lowest is $3.6278.
Disclaimer: The information on this page is not intended to be financial advice. It is for general information only and should not be used to make any investment decisions. Please consult with a professional financial advisor before making any investment decisions.
12-Month LYEL Price Target
Average 3.1135
(-90.96% Downside)
Is Lyell Immunopharma Inc (LYEL) A Buy Now?
Oscillators
| Name | Value | Action |
|---|---|---|
| RSI(14) | 82.57 | Sell |
| STOCH(9,6) | 92.36 | Sell |
| STOCHRSI(14) | 100.00 | Sell |
| MACD(12,26) | 3.8052 | Buy |
| ADX(14) | 53.12 | Buy |
| William %R | -4.3424 | Sell |
| CCI(14) | 112.26 | Buy |
Buy: 3
Sell: 4
Neutral: 0
Summary: Sell
Moving Averages
| Period | Simple | Exponential |
|---|---|---|
| MA10 |
27.26
Buy
|
28.56
Buy
|
| MA20 |
23.62
Buy
|
25.18
Buy
|
| MA50 |
19.81
Buy
|
20.73
Buy
|
| MA100 |
15.99
Buy
|
17.53
Buy
|
| MA200 |
12.94
Buy
|
16.29
Buy
|
Buy: 10
Sell: 0
Neutral: 0
Summary: Buy
According to our latest analysis, LYEL could be considered a Strong Buy, with 17 technical analysis indicators signaling 13 Buy signals, 4 signaling Sell signals and 0 Neutral signals. This might be a good time to open fresh positions on LYEL, as trading bullish markets is always a lot easier
- RSI (Relative Strength Index): The RSI(14) value of 82.57 indicates that LYEL is overbought. This suggests that LYEL price has experienced a significant increase over a specified lookback period, potentially leading to a correction.
- STOCH (Stochastic Oscillator): The STOCH value of 92.36 indicates that LYEL is oversold. This means that LYEL price is at or near the highest level over a specified lookback period.
- STOCHRSI (Stochastic Relative Strength Index): The STOCHRSI value of 100 indicates that LYEL is oversold. This suggests that LYEL price is at or near the highest level relative to its recent price history.
- ADX (Average Directional Index): The ADX value of The ADX value of 53.12 suggests an extremely strong trend in the market. Such high values are relatively rare and indicate a very robust directional movement.
- CCI (Commodity Channel Index): A CCI(14) value of A CCI(14) value of 112.26 indicates that LYEL is overbought. This means that the price has moved significantly higher than its average, indicating a potential selling opportunity.
Long-term LYEL price forecast for 2025, 2030, 2035, 2040, 2045 and 2050
Based on our analysis about Lyell Immunopharma Inc financial reports and earnings history, Lyell Immunopharma Inc (LYEL) stock could reach $6.4991 by 2030, $59.88 by 2040 and $90.83 by 2050. See the projected annual prices until 2050 of the Lyell Immunopharma Inc stock below:
- Lyell Immunopharma Inc (LYEL) is expected to reach an average price of $25.15 in 2035, with a high prediction of $26.11 and a low estimate of $26.12. This indicates an $-27.02% rise from the last recorded price of $34.46.
- Lyell Immunopharma Inc (LYEL) stock is projected to chart a bullish course in 2040, with an average price target of $60.07, representing an $74.32% surge from its current level. The forecast ranges from a conservative $7.9978 to a sky-high $59.88.
- Our analysts predict Lyell Immunopharma Inc (LYEL) to jump 21.33% by 2045, soaring from $41.99 to an average price of $41.81, potentially reaching $42.69. While $41.99 is the low estimate, the potential upside is significant.
- Lyell Immunopharma Inc (LYEL) stock is expected to climb by 2050, reaching an average of $88.97, a $158.17% jump from its current level. However, a wide range of estimates exists, with high and low targets of $90.83 and $89.51, respectively, highlighting the market's uncertainty.
Lyell Immunopharma Inc Stock (LYEL) Year by Year Forecast
Lyell Immunopharma Inc Stock (LYEL) Price Forecast for 2026
The predicted value for Lyell Immunopharma Inc (LYEL) in 2026 is set at an average of $3.1135. Estimates vary from a peak of $4.2863 to a trough of $1.9407, indicating an -90.96% surge from the present price of $34.46.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2026 | $3.8487 | $3.6278 | $3.5095 | -88.83% |
| February, 2026 | $4.2322 | $4.3022 | $4.2863 | -87.72% |
| March, 2026 | $3.8357 | $4.2057 | $4.1381 | -88.87% |
| April, 2026 | $3.3951 | $3.7325 | $3.6492 | -90.15% |
| May, 2026 | $2.4286 | $2.9386 | $3.131 | -92.95% |
| June, 2026 | $2.1021 | $2.6021 | $2.0345 | -93.90% |
| July, 2026 | $2.1015 | $2.2356 | $2.0038 | -93.90% |
| August, 2026 | $2.5449 | $2.1573 | $2.3499 | -92.61% |
| September, 2026 | $2.7743 | $2.2626 | $2.4145 | -91.95% |
| October, 2026 | $2.5678 | $2.8878 | $2.7111 | -92.55% |
| November, 2026 | $1.8113 | $2.4313 | $2.4737 | -94.74% |
| December, 2026 | $1.7207 | $1.9407 | $1.8698 | -95.01% |
Lyell Immunopharma Inc Stock (LYEL) Price Forecast for 2027
For 2027, Stockscan's Analyst expects the average price target for Lyell Immunopharma Inc (LYEL) is $7.7606, with a high forecast of $15.48 and a low forecast of $0.0458. This indicates an -77.48% decrease from the last price of $34.46.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2027 | $1.4342 | $1.4692 | $1.4416 | -95.84% |
| February, 2027 | $1.0377 | $1.2359 | $1.0001 | -96.99% |
| March, 2027 | $0.4071 | $0.9171 | $1.0894 | -98.82% |
| April, 2027 | $0.3806 | $0.1797 | $0.6509 | -98.90% |
| May, 2027 | $0.7259 | $0.2241 | $0.8609 | -97.89% |
| June, 2027 | $10.15 | $0.0458 | $9.96 | -70.55% |
| July, 2027 | $7.967 | $8.9152 | $9.4317 | -76.88% |
| August, 2027 | $9.174 | $9.2587 | $11.66 | -73.38% |
| September, 2027 | $9.3827 | $9.7227 | $10.34 | -72.77% |
| October, 2027 | $13.47 | $9.6245 | $11.82 | -60.91% |
| November, 2027 | $13.93 | $13.72 | $12.75 | -59.59% |
| December, 2027 | $16.40 | $14.95 | $15.48 | -52.42% |
Lyell Immunopharma Inc Stock (LYEL) Price Forecast for 2028
In 2028, Lyell Immunopharma Inc (LYEL) is projected to reach an average price of $12.45, with a high projection of $15.69 and a low estimate of $9.2107. This indicates an -63.87% fall from the last price of $34.46.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2028 | $15.07 | $15.61 | $15.69 | -56.26% |
| February, 2028 | $14.08 | $13.98 | $14.00 | -59.14% |
| March, 2028 | $14.60 | $14.20 | $14.50 | -57.64% |
| April, 2028 | $14.32 | $14.47 | $14.16 | -58.46% |
| May, 2028 | $14.66 | $14.30 | $14.64 | -57.45% |
| June, 2028 | $11.63 | $12.89 | $13.62 | -66.25% |
| July, 2028 | $11.88 | $11.92 | $11.40 | -65.53% |
| August, 2028 | $10.10 | $10.21 | $11.53 | -70.70% |
| September, 2028 | $9.0337 | $9.8737 | $9.9702 | -73.78% |
| October, 2028 | $9.0407 | $9.2107 | $8.6972 | -73.76% |
| November, 2028 | $9.7894 | $9.4724 | $9.4377 | -71.59% |
| December, 2028 | $10.75 | $10.90 | $10.62 | -68.81% |
Lyell Immunopharma Inc Stock (LYEL) Price Forecast for 2029
The 2029 price forecast for Lyell Immunopharma Inc Stock (LYEL) is $8.9904 on average, with a high prediction of $11.20 and a low estimate of $6.7824. This represents an -73.91% decrease from the previous price of $34.46.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2029 | $10.85 | $10.94 | $11.20 | -68.53% |
| February, 2029 | $10.46 | $10.93 | $10.65 | -69.64% |
| March, 2029 | $10.68 | $10.40 | $10.38 | -69.01% |
| April, 2029 | $10.79 | $10.75 | $10.80 | -68.70% |
| May, 2029 | $9.7749 | $9.7999 | $10.25 | -71.63% |
| June, 2029 | $9.1019 | $9.4619 | $9.5884 | -73.59% |
| July, 2029 | $7.6089 | $8.2439 | $8.4637 | -77.92% |
| August, 2029 | $7.5377 | $7.5509 | $7.3942 | -78.13% |
| September, 2029 | $7.0647 | $7.1347 | $7.1119 | -79.50% |
| October, 2029 | $6.9234 | $7.2534 | $7.1349 | -79.91% |
| November, 2029 | $7.3404 | $6.8551 | $7.1104 | -78.70% |
| December, 2029 | $6.7374 | $6.7824 | $7.0471 | -80.45% |
Lyell Immunopharma Inc Stock (LYEL) Price Forecast for 2030
Lyell Immunopharma Inc Stock (LYEL) is expected to reach an average price of $13.00 in 2030, with a high forecast of $24.08 and a low forecast of $1.9151. This signifies an -62.29% decrease from the last price of $34.46.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2030 | $5.7061 | $6.1061 | $6.4991 | -83.44% |
| February, 2030 | $5.2131 | $5.3231 | $5.5646 | -84.87% |
| March, 2030 | $4.5801 | $4.7196 | $4.6866 | -86.71% |
| April, 2030 | $4.2771 | $4.2821 | $4.1519 | -87.59% |
| May, 2030 | $2.5459 | $3.1059 | $4.0789 | -92.61% |
| June, 2030 | $3.0329 | $2.3976 | $2.7629 | -91.20% |
| July, 2030 | $2.1416 | $2.2016 | $2.5646 | -93.79% |
| August, 2030 | $22.11 | $1.9151 | $22.44 | -35.85% |
| September, 2030 | $18.53 | $21.20 | $20.16 | -46.23% |
| October, 2030 | $22.59 | $23.02 | $23.69 | -34.46% |
| November, 2030 | $20.93 | $21.21 | $21.25 | -39.27% |
| December, 2030 | $24.43 | $23.75 | $24.08 | -29.11% |
1.08%
0.91%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):